Cited by 291Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 60 of the 61 references it cites were found in a registry or an index.

Activation of c-Jun N-Terminal Kinase and p38 in an Alzheimer's Disease Model Is Associated with Amyloid Deposition

Open access

Savage, Mary J., Lin, Yin-Guo, Ciallella, John R., Flood, Dorothy G., Scott, Richard W.·2002·The Journal of Neuroscience

DOI 10.1523/jneurosci.22-09-03376.2002PMC PMC6758401

Open this paper in CoChat — free account Open PDF

Abstract

The mechanisms by which neurons and synapses are lost in Alzheimer's disease (AD) are not completely understood. To characterize potential signaling events linked to AD pathogenesis, activation-specific antibodies were used to examine mitogen-activated protein kinase (MAPK) kinase pathways at various ages in mice transgenic for human amyloid precursor protein-695 with the Swedish familial AD mutations (Tg2576) and homozygous for a P264L familial AD mutation introduced by targeting of the presenilin-1 gene (PS1(P264L)). Although the c-Jun N-terminal kinase (JNK) and p38 pathways were significantly activated in the cortex at both 7 and 12 months of age, there was no significant activation of the extracellular signal-regulated kinase pathway. MAPK kinase-4, an upstream activator of JNK, was also significantly activated at 7 and 12 months, whereas c-Jun, a downstream effector of JNK-associated apoptotic signaling, was not induced. The lack of c-Jun activation is consistent with the absence of neuronal loss in both cortex and hippocampal CA1 at 12 months. The JNK activation was localized to amyloid deposits, within neurites containing phosphorylated tau. Synaptophysin was quantified biochemically as a measure of synaptic integrity and was significantly reduced in an age-dependent manner in the Tg2576/PS1(P264L) cortex but not in either PS1(P264L) or Tg2576 cortex. Stress-responsive MAP kinase pathways were activated in the brain of the Tg2576/PS1(P264L) AD model, and this activation was coincident with the age-dependent increase in amyloid deposition, tau phosphorylation, and loss of synaptophysin.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1523/jneurosci.22-09-03376.2002

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Mammalian MAP kinase signalling cascades
Chang, L., & Karin, M. (2001) · Nature · doi:10.1038/35065000 · Cited by 5,118
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Mammalian Mitogen-Activated Protein Kinase Signal Transduction Pathways Activated by Stress and Inflammation
Kyriakis, J. M., & Avruch, J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.807 · Cited by 3,400
Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
High-Level Neuronal Expression of Aβ1–42in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856
Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
Gómez‐Isla, T., Hollister, R., West, H., Mui, S., Growdon, J. H., Petersen, R. C., Parisi, J. E., & Hyman, B. T. (1997) · Annals of Neurology · doi:10.1002/ana.410410106 · Cited by 1,489
Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease
West, M. J., Coleman, P. D., Flood, D. G., & Troncoso, J. C. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92338-8 · Cited by 1,267 · cited 2×
“The memory impairments in Alzheimer’s disease (AD) are attributable to the loss of both neurons and synapses (West et al., 1994; DeKosky et al., 1996; Gomez-Isla et al., 1997).”
BackgroundSelf-citation

Show all 61 references

Sorted by citations

Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution
Stefani, M., & Dobson, C. M. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0464-5 · Cited by 1,670
Lipopolysaccharide-Induced Inflammation Exacerbates Tau Pathology by a Cyclin-Dependent Kinase 5-Mediated Pathway in a Transgenic Model of Alzheimer's Disease
Kitazawa, M., Oddo, S., Yamasaki, T. R., Green, K. N., & LaFerla, F. M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2868-05.2005 · Cited by 697
CD14 and Toll-Like Receptors 2 and 4 Are Required for Fibrillar Aβ-Stimulated Microglial Activation
Reed-Geaghan, E. G., Savage, J. C., Hise, A. G., & Landreth, G. E. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3158-09.2009 · Cited by 591
Neuropathology and Pathogenesis of Encephalitis following Amyloid β Immunization in Alzheimer's Disease
Ferrer, I., Rovira, M. B., Guerra, M. L. S., Rey, M. J., & Costa‐Jussá, F. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00493.x · Cited by 479
-Amyloid Oligomers Induce Phosphorylation of Tau and Inactivation of Insulin Receptor Substrate via c-Jun N-Terminal Kinase Signaling: Suppression by Omega-3 Fatty Acids and Curcumin
Ma, Q.-L., Yang, F., Rosario, E. R., Ubeda, O. J., Beech, W., Gant, D. J., Chen, P. P., Hudspeth, B., Chen, C., Zhao, Y., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1071-09.2009 · Cited by 536
Ageing, Cellular Senescence and Neurodegenerative Disease
Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102937 · Cited by 448
“Since p38MAPK is a major regulator of SASP [209], it is not surprising that a number of key components of SASP appear to be up-regulated in AD [210,211].”
Background
Block of Long-Term Potentiation by Naturally Secreted and Synthetic Amyloid β-Peptide in Hippocampal Slices Is Mediated via Activation of the Kinases c-Jun N-Terminal Kinase, Cyclin-Dependent Kinase 5, and p38 Mitogen-Activated Protein Kinase as well as Metabotropic Glutamate Receptor Type 5
Wang, Q., Walsh, D. M., Rowan, M. J., Selkoe, D. J., & Anwyl, R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1633-03.2004 · Cited by 437
c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer’s Disease
Yarza, R., Vela, S., Solas, M., & Ramírez, M. J. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00321 · Cited by 428
The Role of Mitogen-Activated Protein Kinase Pathways in Alzheimer’s Disease
Zhu, X., Lee, H., Raina, A. K., Perry, G. L., & Smith, M. A. (2002) · Neurosignals · doi:10.1159/000067426 · Cited by 392
Oxidative stress signalling in Alzheimer's disease
Zhu, X., Raina, A. K., Lee, H., Casadesús, G., Smith, M. A., & Perry, G. L. (2004) · Brain Research · doi:10.1016/j.brainres.2004.01.012 · Cited by 396
Tumor Necrosis Factor-α, Interleukin-1β, and Interferon-γ Stimulate γ-Secretase-mediated Cleavage of Amyloid Precursor Protein through a JNK-dependent MAPK Pathway
Liao, Y.-F., Wang, B.-J., Cheng, H.-T., Kuo, L.-H., & Wolfe, M. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402034200 · Cited by 389
Role of Redox Signaling in Neuroinflammation and Neurodegenerative Diseases
Hsieh, H., & Yang, C. (2013) · BioMed Research International · doi:10.1155/2013/484613 · Cited by 372
Inflammation in Alzheimer's disease: Amyloid-β oligomers trigger innate immunity defence via pattern recognition receptors
Salminen, A., Ojala, J. O., Kauppinen, A., Kaarniranta, K., & Suuronen, T. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.01.001 · Cited by 360
Oxidative Stress Signaling in Alzheimers Disease
Su, B., Wang, X., Nunomura, A., Moreira, P., Lee, H.-G., Perry, G., Smith, M., & Zhu, X. (2008) · Current Alzheimer Research · doi:10.2174/156720508786898451 · Cited by 344
Nuclear and cytosolic JNK signalling in neurons
Coffey, E. T. (2014) · Nature reviews. Neuroscience · doi:10.1038/nrn3729 · Cited by 351
RAGE‐dependent signaling in microglia contributes to neuroinflammation, Aβ accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease
Fang, F., Lue, L.-F., Yan, S., Xu, H., Luddy, J. S., Chen, D., Walker, D. G., Stern, D. M., Yan, S., Schmidt, A. M., et al. (2010) · The FASEB Journal · doi:10.1096/fj.09-139634 · Cited by 335
β‐Site APP cleaving enzyme up‐regulation induced by 4‐hydroxynonenal is mediated by stress‐activated protein kinases pathways
Tamagno, E., Parola, M., Bardini, P., Piccini, A., Borghi, R., Guglielmotto, M., Santoro, G., Davit, A., Danni, O., Smith, M. A., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02895.x · Cited by 324
Current Advances on Different Kinases Involved in Tau Phosphorylation, and Implications in Alzheimers Disease and Tauopathies
Ferrer, I., Gómez‐Isla, T., Puig, B., Freixes, M., Ribé, E. M., Dalfó, E., & Ávila, J. (2005) · Current Alzheimer Research · doi:10.2174/1567205052772713 · Cited by 309
Shaping the Nrf2-ARE-related pathways in Alzheimer’s and Parkinson’s diseases
Fão, L., Mota, S. I., & Rego, A. C. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100942 · Cited by 281
The Role of p38 MAPK and Its Substrates in Neuronal Plasticity and Neurodegenerative Disease
Corrêa, S. A. L., & Eales, K. L. (2012) · Journal of Signal Transduction · doi:10.1155/2012/649079 · Cited by 258
Importance of MAPK pathways for microglial pro-inflammatory cytokine IL-1β production
Kim, S. H., Smith, C. J., & Eldik, L. J. V. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00126-x · Cited by 241
A novel p38α MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model
Munoz, L., Ranaivo, H. R., Roy, S. M., Hu, W., Craft, J. M., McNamara, L. K., Chico, L. W., Van Eldik, L. J., & Watterson, D. M. (2007) · Journal of Neuroinflammation · doi:10.1186/1742-2094-4-21 · Cited by 224
JNK Signalling: A Possible Target to Prevent Neurodegeneration
Borsello, T., & Forloni, G. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207780858384 · Cited by 226
P38 MAP kinase is activated at early stages in Alzheimer's disease brain
Sun, A. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00180-8 · Cited by 219
Treadmill exercise represses neuronal cell death in an aged transgenic mouse model of Alzheimer's disease
Um, H.-S., Kang, E., Koo, J., Kim, H.-T., Jin-Lee, Kim, E.-J., Yang, C., An, G.-Y., Cho, I., & Cho, J. (2010) · Neuroscience Research · doi:10.1016/j.neures.2010.10.004 · Cited by 212
Molecular Mechanisms and Genetics of Oxidative Stress in Alzheimer’s Disease
Cioffi, F., Adam, R. H. I., & Broersen, K. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190863 · Cited by 204
“Pre1197 treatment of these NT2 cells with -tocopherol 1198 prevented BACE induction and CTF generation 1199 demonstrating direct involvement of oxidative stress 1200 in inducing BACE activity [81, 297].”
Background
Loss of α7 Nicotinic Receptors Enhances β-Amyloid Oligomer Accumulation, Exacerbating Early-Stage Cognitive Decline and Septohippocampal Pathology in a Mouse Model of Alzheimer's Disease
Hernandez, C. M., Kayed, R., Zheng, H., Sweatt, J. D., & Dineley, K. T. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5038-09.2010 · Cited by 204
“Previous studies on APP mice have failed to detect robust deficits in synaptophysin at any age, and MAP2 decline has only been reported for aged APP animals (9 –24 months old) (Savage et al., 2002; Fonseca et al., 2004).”
Background
JNK pathway: diseases and therapeutic potential
Cui, J., Zhang, M., Zhang, Y., & Xu, Z. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00579.x · Cited by 202
Neurotoxic Mechanisms Caused by the Alzheimer's Disease-linked Swedish Amyloid Precursor Protein Mutation
Marques, C. A., Keil, U., Bonert, A., Steiner, B., Haass, C., Müller, W. E., & Eckert, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212265200 · Cited by 179
Essential Role of E2-25K/Hip-2 in Mediating Amyloid-β Neurotoxicity
Song, S., Kim, S., Hong, Y., Jo, D., Lee, J., Shim, S. M., Chung, C., Seo, S. J., Yoo, Y. J., Koh, J., et al. (2003) · Molecular Cell · doi:10.1016/j.molcel.2003.08.005 · Cited by 167
Sleep and circadian abnormalities in a transgenic mouse model of Alzheimer’s disease: A role for cholinergic transmission
Wisor, J. P., Edgar, D. M., Yesavage, J. A., Ryan, H. S., McCormick, C. M., Lapustea, N., & Murphy, G. M. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2004.11.018 · Cited by 173
Insulin deficiency exacerbates cerebral amyloidosis and behavioral deficits in an Alzheimer transgenic mouse model
Wang, X., Zheng, W. H., Xie, J., Wang, T., Wang, S., Teng, W., & Wang, Z. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-46 · Cited by 161
Ras and Rap Signaling in Synaptic Plasticity and Mental Disorders
Stornetta, R. L., & Zhu, J. (2010) · The Neuroscientist · doi:10.1177/1073858410365562 · Cited by 161
Increased MAP kinase activity in Alzheimer's and Down syndrome but not in schizophrenia human brain
SWATTON, J. E., Sellers, L. A., Faull, R. L. M., Holland, A. J., Iritani, S., & Bahn, S. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03365.x · Cited by 158
Activation of the ERK and JNK signaling pathways caused by neuron-specific inhibition of PP2A in transgenic mice
Kins, S., Kurosinski, P., Nitsch, R. M., & Götz, J. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63444-x · Cited by 155
The p38 MAP Kinase Family as Regulators of Proinflammatory Cytokine Production in Degenerative Diseases of the CNS.
Bachstetter, A. D., & Eldik, L. J. V. (2010) · PubMed Central · Cited by 155
Cellular Signaling Mechanisms for Muscarinic Acetylcholine Receptors
Lanzafame, A. A., Christopoulos, A., & Mitchelson, F. J. (2003) · Receptors and Channels · doi:10.3109/10606820308263 · Cited by 147
Tyk2/STAT3 Signaling Mediates β-Amyloid-Induced Neuronal Cell Death: Implications in Alzheimer's Disease
Wan, J., Fu, A. K. Y., Ip, F. C. F., Ng, H., Hugon, J., Page, G., Wang, J. H.-C., Lai, K., Wu, Z., & Ip, N. Y. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0519-10.2010 · Cited by 150
Glia Proinflammatory Cytokine Upregulation as a Therapeutic Target for Neurodegenerative Diseases: Function‐Based and Target‐Based Discovery Approaches
Eldik, L. J. V., Thompson, W. L., Ranaivo, H. R., Behanna, H. A., & Watterson, D. M. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(07)82015-0 · Cited by 141
Role of Hydrogen Peroxide in the Aetiology of Alzheimer??s Disease
Milton, N. G. N. (2004) · Drugs & Aging · doi:10.2165/00002512-200421020-00002 · Cited by 141
Insulin Resistance at the Crossroad of Alzheimer Disease Pathology: A Review
Berlanga‐Acosta, J., Guillén, G. E., Rodríguez-Rodríguez, N., Bringas-Vega, M. L., García-del-Barco-Herrera, D., Berlanga-Saez, J. O., Ojalvo, A. G., Valdés-Sosa, M. J., & Valdes-Sosa, P. A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.560375 · Cited by 143
FoxO3a is activated and executes neuron death via Bim in response to β-amyloid
Sanphui, P., & Biswas, S. C. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.148 · Cited by 137
Promising therapeutic potential of pterostilbene and its mechanistic insight based on preclinical evidence
Kosuru, R., Rai, U., Prakash, S., Singh, A., & Singh, S. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.07.046 · Cited by 139
Molecular mechanisms linking amyloid β toxicity and Tau hyperphosphorylation in Alzheimer׳s disease
Lloret, A., Fuchsberger, T., Giraldo, E., & Viña, J. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.02.028 · Cited by 135
Protection by EGb 761 against β-amyloid-induced neurotoxicity: Involvement of NF-κB, SIRT1, and MAPKs pathways and inhibition of amyloid fibril formation
Longpré, F., Garneau, P., Christen, Y., & Ramassamy, C. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.08.015 · Cited by 132
Redox regulates COX-2 upregulation and cell death in the neuronal response to cadmium
Rockwell, P. (2003) · Cellular Signalling · doi:10.1016/j.cellsig.2003.08.006 · Cited by 132
Targeting JNK3 for the treatment of neurodegenerative disorders
Resnick, L., & Fennell, M. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03251-9 · Cited by 128
β-Amyloid-induced Dynamin 1 Depletion in Hippocampal Neurons
Kelly, B. L., Vassar, R. J., & Ferreira, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503259200 · Cited by 129
The role of TNF-α signaling pathway on COX-2 upregulation and cognitive decline induced by β-amyloid peptide
Medeiros, R., Figueiredo, C. P., Pandolfo, P., Duarte, F. S., Prediger, R. D. S., Passos, G. F., & Calixto, J. B. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.01.040 · Cited by 121
Herp Stabilizes Neuronal Ca2+ Homeostasis and Mitochondrial Function during Endoplasmic Reticulum Stress
Chan, S. L., Fu, W., Zhang, P., Cheng, A., Lee, J., Kokame, K., & Mattson, M. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404272200 · Cited by 118
Activation of the c-Jun N-terminal Kinase Signaling Cascade Mediates the Effect of Amyloid-β on Long Term Potentiation and Cell Death in Hippocampus
Minogue, A. M., Schmid, A. W., Fogarty, M. P., Moore, A. C., Campbell, V. A., Herron, C. E., & Lynch, M. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302530200 · Cited by 117
Are there roles for brain cell senescence in aging and neurodegenerative disorders?
Tan, F. C. C., Hutchison, E. R., Eitan, E., & Mattson, M. P. (2014) · Biogerontology · doi:10.1007/s10522-014-9532-1 · Cited by 116
MKP-1 reduces Aβ generation and alleviates cognitive impairments in Alzheimer’s disease models
Du, Y., Du, Y., Zhang, Y., Huang, Z., Fu, M., Li, J., Pang, Y., Lei, P., Wang, Y. T., Song, W., et al. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0091-4 · Cited by 117
p38 MAP Kinase Inhibitors as Potential Therapeutic Drugs for Neural Diseases
Yasuda, S., Sugiura, H., Tanaka, H., Takigami, S., & Yamagata, K. (2011) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/187152411794961040 · Cited by 112
MAPKs: new targets for neurodegeneration
Harper, S. J., & Wilkie, N. M. (2003) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.7.2.187 · Cited by 111
Vanillic Acid, a Bioactive Phenolic Compound, Counteracts LPS-Induced Neurotoxicity by Regulating c-Jun N-Terminal Kinase in Mouse Brain
Ullah, R., Ikram, M. A., Park, T. J., Ahmad, R., Saeed, K. M., Alam, S. I., Rehman, I. U., Khan, A., Khan, I., Jo, M. G., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010361 · Cited by 113
The p38 MAP kinase signaling pathway in Alzheimer's disease
Johnson, G. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00268-1 · Cited by 106
Inhibition of c‐ J un N ‐terminal kinase activation reverses A lzheimer disease phenotypes in APP swe/ PS 1dE 9 mice
Zhou, Q., Wang, M., Du, Y., Zhang, W., Bai, M., Zhang, Z., Li, Z., & Miao, J. (2015) · Annals of Neurology · doi:10.1002/ana.24361 · Cited by 105
Synergistic Effects of the SAPK/JNK and the Proteasome Pathway on Glial Fibrillary Acidic Protein (GFAP) Accumulation in Alexander Disease
Tang, G., Xu, Z., & Goldman, J. E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604942200 · Cited by 104
Photobiomodulation by low-power laser irradiation attenuates Aβ-induced cell apoptosis through the Akt/GSK3β/β-catenin pathway
Liang, J., Liu, L., & Xing, D. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.08.003 · Cited by 102
Microglial p38α MAPK is critical for LPS-induced neuron degeneration, through a mechanism involving TNFα
Xing, B., Bachstetter, A. D., & Van Eldik, L. J. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-84 · Cited by 101
Hippocampal Injections of Oligomeric Amyloid β-peptide (1–42) Induce Selective Working Memory Deficits and Long-lasting Alterations of ERK Signaling Pathway
Faucher, P., Mons, N., Micheau, J., Louis, C., & Beracochea, D. J. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00245 · Cited by 100
Inhibition of γ-secretase activity reduces Aβ production, reduces oxidative stress, increases mitochondrial activity and leads to reduced vulnerability to apoptosis: Implications for the treatment of Alzheimer's disease
Sheng, B., Gong, K., Niu, Y., Liu, L., Yan, Y., Lu, G., Zhang, L., Hu, M., Zhao, N., Zhang, X., et al. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.02.018 · Cited by 98
Signal Transduction Cascades Associated with Oxidative Stress in Alzheimer's Disease
Petersen, R. B., Nunomura, A., Lee, H., Casadesús, G., Perry, G. L., Smith, M. A., & Zhu, X. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-11202 · Cited by 101
Antagonizing β-amyloid peptide neurotoxicity of the anti-aging fungus Ganoderma lucidum
Lai, C. S.-W., Yu, M.-S., Yuen, W.-H., So, K., Zee, S., & Chang, R. C. (2007) · Brain Research · doi:10.1016/j.brainres.2007.10.103 · Cited by 93
VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice
El Gaamouch, F., Audrain, M., Lin, W.-J., Beckmann, N., Jiang, C., Hariharan, S., Heeger, P. S., Schadt, E. E., Gandy, S., Ehrlich, M. E., et al. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-0357-x · Cited by 92
The cell cycle as a therapeutic target for Alzheimer's disease
Neve, R. L., & McPhie, D. L. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.09.005 · Cited by 92
Omega-3 polyunsaturated fatty acids in the brain: metabolism and neuroprotection
Zhang, W. (2011) · Frontiers in bioscience · doi:10.2741/3878 · Cited by 94
Aberrant phosphorylation in the pathogenesis of Alzheimer's disease
Chung, S. (2009) · BMB Reports · doi:10.5483/bmbrep.2009.42.8.467 · Cited by 92
p53-dependent SIRT6 expression protects Aβ42-induced DNA damage
Jung, E. S., Choi, H., Song, H., Hwang, Y. J., Kim, A., Ryu, H., & Mook‐Jung, I. (2016) · Scientific Reports · doi:10.1038/srep25628 · Cited by 91
JNK3 as a Therapeutic Target for Neurodegenerative Diseases
Antoniou, X., Falconi, M., Marino, D. D., & Borsello, T. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-091567 · Cited by 87
Expression of stress‐activated kinases c‐Jun N‐terminal kinase (SAPK/JNK‐P) and p38 kinase (p38‐P), and tau hyperphosphorylation in neurites surrounding βA plaques in APP Tg2576 mice
Puig, B., Gómez‐Isla, T., Ribé, E. M., Cuadrado‐Tejedor, M., Torrejón-Escribano, B., Dalfó, E., & Ferrer, I. (2004) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2004.00569.x · Cited by 88
A transgenic rat model of Alzheimer's disease with extracellular Aβ deposition
Flood, D. G., Lin, Y., Lang, D. M., Trusko, S. P., Hirsch, J. D., Savage, M. J., Scott, R. W., & Howland, D. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.10.006 · Cited by 90
Self-citation
JNK and ERK1/2 pathways have a dual opposite effect on the expression of BACE1
Tamagno, E., Guglielmotto, M., Giliberto, L., Vitali, A., Borghi, R., Autelli, R., Danni, O., & Tabaton, M. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.12.015 · Cited by 84
c-Jun N-terminal Kinase Regulates Soluble Aβ Oligomers and Cognitive Impairment in AD Mouse Model
Sclip, A., Antoniou, X., Colombo, A. V., Camici, G. G., Pozzi, L., Cardinetti, D., Feligioni, M., Veglianese, P., Bahlmann, F. H., Cervo, L., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.297515 · Cited by 86
Neuroprotective strategies in Alzheimer’s disease
Longo, F. M., & Massa, S. M. (2004) · NeuroRx · doi:10.1602/neurorx.1.1.117 · Cited by 83
Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease
Wu, Z., Ciallella, J. R., Flood, D. G., O’Kane, T. M., Bozyczko‐Coyne, D., & Savage, M. J. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.02.010 · Cited by 84
Self-citation
Inflammasome NLRP3 Potentially Links Obesity-Associated Low-Grade Systemic Inflammation and Insulin Resistance with Alzheimer’s Disease
Litwiniuk, A., Bik, W., Kalisz, M., & Baranowska-Bik, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115603 · Cited by 82
Inhibition of c-Jun kinase provides neuroprotection in a model of Alzheimer's disease
Braithwaite, S. P., Schmid, R. S., Dong, H., Sung, M.-L. A., Cho, S., Resnick, L., Monaghan, M. M., Hirst, W. D., Essrich, C., Reinhart, P. H., et al. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.04.015 · Cited by 82
Caffeine induces beneficial changes in PKA signaling and JNK and ERK activities in the striatum and cortex of Alzheimer's transgenic mice
Zeitlin, R., Patel, S., Burgess, S., Arendash, G. W., & Echeverrı́a, V. (2011) · Brain Research · doi:10.1016/j.brainres.2011.08.036 · Cited by 84
Intranasal deferoxamine attenuates synapse loss via up-regulating the P38/HIF-1α pathway on the brain of APP/PS1 transgenic mice
Guo, C., Zhang, Y., Wang, T., Zhong, M., Yang, Z., Hao, L.-J., Chai, R., & Zhang, S. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00104 · Cited by 80
Drug Discovery of DKK1 Inhibitors
Jiang, H., Zhang, Z., Yu, Y., Chu, H. Y., Yu, S., Yao, S., Zhang, G., & Zhang, B. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.847387 · Cited by 79
The regulation of p53 up‐regulated modulator of apoptosis by JNK /c‐Jun pathway in β‐amyloid‐induced neuron death
Akhter, R., Sanphui, P., Das, H., Saha, P., & Biswas, S. C. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13128 · Cited by 78
RETRACTED: 5‐Lipoxygenase gene transfer worsens memory, amyloid, and tau brain pathologies in a mouse model of alzheimer disease
Chu, J., Giannopoulos, P. F., Ceballos‐Diaz, C., Golde, T. E., & Praticò, D. (2012) · Annals of Neurology · doi:10.1002/ana.23642 · Cited by 78
Retracted
p38 MAP kinase-mediated NMDA receptor-dependent suppression of hippocampal hypersynchronicity in a mouse model of Alzheimer’s disease
Ittner, A., Gladbach, A., Bertz, J., Suh, L. S., & Ittner, L. M. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0149-z · Cited by 80
Green tea catechin leads to global improvement among Alzheimer's disease-related phenotypes in NSE/hAPP-C105 Tg mice
Lim, H. J., Shim, S. B., Jee, S. W., Lee, S. H., Lim, C. J., Hong, J. T., Sheen, Y. Y., & Hwang, D. Y. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.10.005 · Cited by 77
Signal transduction in Alzheimer disease: p21‐activated kinase signaling requires C‐terminal cleavage of APP at Asp664
Nguyen, T. V., Galván, V., Huang, W., Banwait, S., Tang, H., Zhang, J., & Bredesen, D. E. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05031.x · Cited by 78
Loss of Interleukin Receptor-Associated Kinase 4 Signaling Suppresses Amyloid Pathology and Alters Microglial Phenotype in a Mouse Model of Alzheimer's Disease
Cameron, B., Tse, W., Lamb, R., Li, X., Lamb, B. T., & Landreth, G. E. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1729-12.2012 · Cited by 76
Characterization of the Signaling Pathway Downstream p75 Neurotrophin Receptor Involved in β-Amyloid Peptide-Dependent Cell Death
Costantini, C., Rossi, F., Formaggio, E., Bernardoni, R., Cecconi, D., & Bianca, V. D. (2005) · Journal of Molecular Neuroscience · doi:10.1385/jmn:25:2:141 · Cited by 74
Cdk5 is a major regulator of p38 cascade: relevance to neurotoxicity in Alzheimer’s disease
Chang, K., de Pablo, Y., Lee, H., Lee, H., Smith, M. A., & Shah, K. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06687.x · Cited by 77
Stress and ageing interactions: A paradox in the context of shared etiological and physiopathological processes
Pardon, M. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.02.007 · Cited by 77
A Single c-Jun N-terminal Kinase Isoform (JNK3-p54) Is an Effector in Both Neuronal Differentiation and Cell Death
Waetzig, V., & Herdegen, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207391200 · Cited by 72
MAPK, β-amyloid and synaptic dysfunction: the role of RAGE
Origlia, N., Arancio, O., Domenici, L., & Yan, S. S. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.107 · Cited by 71
Hippocampal metabotropic glutamate receptor long‐term depression in health and disease: focus on mitogen‐activated protein kinase pathways
Sanderson, T. M., Hogg, E. L., Collingridge, G. L., & Corrêa, S. A. L. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13592 · Cited by 72
Genetically Augmenting Aβ42 Levels in Skeletal Muscle Exacerbates Inclusion Body Myositis-Like Pathology and Motor Deficits in Transgenic Mice
Kitazawa, M., Green, K. N., Caccamo, A., & LaFerla, F. M. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.051232 · Cited by 73
Insulin-degrading enzyme: Roles and pathways in ameliorating cognitive impairment associated with Alzheimer's disease and diabetes
Tian, Y., Jing, G., & Zhang, M. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101999 · Cited by 77
Aberrant expressions of pathogenic phenotype in Alzheimer's diseased transgenic mice carrying NSE-controlled APPsw
Hwang, D. Y., Cho, J. S., Lee, S. H., Chae, K. R., Lim, H. J., Min, S. H., Seo, S. J., Song, Y. S., Song, C. W., Paik, S. G., et al. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2003.09.021 · Cited by 69
Early effects of Aβ 1-42 oligomers injection in mice: Involvement of PI3K/Akt/GSK3 and MAPK/ERK1/2 pathways
Morroni, F., Sita, G., Tarozzi, A., Rimondini, R., & Hrelia, P. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.08.002 · Cited by 65
Tau Phosphorylation, Molecular Chaperones, and Ubiquitin E3 Ligase: Clinical Relevance in Alzheimer's Disease
Kumar, P., Jha, N. K., Jha, S. K., Ramani, K., & Ambasta, R. K. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140933 · Cited by 67
Reactivation of HSV‐1 in the brain of patients with familial Alzheimer's disease
Mori, I., Kimura, Y., Naiki, H., Matsubara, R., Takeuchi, T., Yokochi, T., & Nishiyama, Y. (2004) · Journal of Medical Virology · doi:10.1002/jmv.20133 · Cited by 67

Authors: Savage, M. J., Lin, Y.-G., Ciallella, J. R., Flood, D. G., & Scott, R. W.
ORCID: Scott, Richard W.
Venue: The Journal of Neuroscience
Publisher: Society for Neuroscience
Published: 2002-05-01
Volume: 22
Issue: 9
Pages: 3376-3385
ISSN: 0270-6474 (ISSN-L)
1529-2401
DOI: 10.1523/jneurosci.22-09-03376.2002
PMC: PMC6758401
OpenAlex: W1558509021
Cited by: 291
References: 61
Citations by year: 2026: 2 · 2025: 9 · 2024: 6 · 2023: 11 · 2022: 10 · 2021: 8 · 2020: 8 · 2019: 15 · 2018: 8 · 2017: 8 · 2016: 16 · 2015: 9 · 2014: 14 · 2013: 9 · 2012: 6
FWCI: 12.81
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Neuroscience (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: Alzheimer's disease, c-Jun N-terminal kinase, p38 MAPK, amyloid deposition, MAPK signaling, Tg2576 mice, amyloid precursor protein, MAPKAPK4, c-Jun, tau phosphorylation, synaptophysin, synaptic integrity, neuronal loss, hippocampal CA1
MeSH terms: Aging, Alzheimer Disease, Amyloid, Animals, Cell Count, Cerebral Cortex, Disease Models, Animal, Enzyme Activation, Hippocampus, Humans, Immunohistochemistry, Membrane Proteins, Mice, Transgenic, Neurons, Phosphorylation, Signal Transduction, Neurites, Amyloid beta-Protein Precursor, Synaptophysin, tau Proteins, Gene Targeting, Amino Acid Substitution, Mitogen-Activated Protein Kinases, JNK Mitogen-Activated Protein Kinases, p38 Mitogen-Activated Protein Kinases, Mice, Presenilin-1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Activation of c-Jun N-Terminal Kinase and p38 in an Alzheimer's Disease Model Is Associated with Amyloid Deposition

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks